MTOR and endometrial cancer: Nonetheless, our study sheds light on a potential therapeutic strategy for endometrial cancer by combining mTORC1 inhibition with ferroptosis induction, and it may inform patient stratification based on PAM pathway status while suggesting broader applicability of this approach to other cancers with hyperactivated mTOR signaling.